Evidence map›Paper›PMID 39729207›Full record

ArticleCell regeneration (London, England)2024

Standard: Human gastric cancer organoids.

Ronghui Tan, Fan Hong, Ting Wang, Nanshan Zhong, Hongling Zhao, Rui-Hua Xu, Lin Shen, Yingbin Liu, Xuebiao Yao, Dongxi Xiang and 25 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell regeneration (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Ronghui Tan *Guangzhou National Laboratory, Guangzhou, 510005, China.
Fan Hong *Guangzhou National Laboratory, Guangzhou, 510005, China.
Ting Wang *The State Key Laboratory of Membrane Biology, Tsinghua‑Peking Center for Life Sciences,, School of Life Sciences , Tsinghua University, Beijing, 100084, China.
Nanshan Zhong *The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, 330031, China.
Hongling ZhaoBeijing Institute for Stem Cell and Regenerative Medicine, Beijing, 100101, China.
Rui-Hua XuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Lin ShenState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Gastrointestinal Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Yingbin LiuState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai Jiaotong University School of Medicine, Shanghai, 200232, China.
Xuebiao YaoMOE Key Laboratory of Cellular Dynamics, CAS Center for Excellence in Molecular Cell Science, University of Science and Technology of China, Hefei, 230027, China.
Dongxi XiangState Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai Jiaotong University School of Medicine, Shanghai, 200232, China.
Dong GaoKey Laboratory of Multi-Cell Systems, Shanghai Key Laboratory of Molecular Andrology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, 200031, China.
Jianping XiongDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330031, China.
Lijian HuiUniversity of Chinese Academy of Sciences, Beijing, 100049, China.
Bing ZhaoThe MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, 330031, China.
Zhifeng MiaoDepartment of Surgical Oncology and General Surgery, The First Hospital of China Medical University, 155N Nanjing Street, Shenyang, Liaoning, 110001, China.
Jie HaoNational Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.
Yong LiDepartment of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Shijun HuDepartment of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Suzhou Medical College, Soochow University, Suzhou, 510080, China.
Boqiang FuNational Institute of Metrology, Beijing, 100029, China.
Guoqiang HuaDepartment of Radiation Oncology and Cancer Institute, Fudan University Shanghai Cancer Center Fudan University, Shanghai, 200433, China.
Lei WangBeijing Institute for Stem Cell and Regenerative Medicine, Beijing, 100101, China.
Zhao-Lei ZengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Chong ChenGastric Cancer Centerand, Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Jianmin WuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Changlin WangChina National Institute of Standardization, Beijing, 100191, China.
Chunnian WangDepartment of Gastrointestinal Pathology, Ningbo Diagnostic Pathology Center, Ningbo, 315021, China.
Xianbao ZhanDepartment of Oncology, Changhai Hospital, Second Military Medical University, No. 168 Changhai Road, Shanghai, 200433, China.
Chen SongHuayi Regeneration Technology Co., Ltd, Chengdu, 611135, China.
Zhijian SunK2 Oncology Co., Ltd, KeChuang Street, Beijing, 100176, China.
Chunping YuLilly (China) Research and Development Center, Shanghai, 201203, China.
Yingying YangQilu Pharmaceutical Co., Ltd, Jinan, 250104, China.
Gengming NiuShanghai OneTar Biomedicine Co., Ltd, Shanghai, 201203, China.
Yalong WangGuangzhou National Laboratory, Guangzhou, 510005, China. wangyl16@tsinghua.org.cn.
Tongbiao ZhaoBeijing Institute for Stem Cell and Regenerative Medicine, Beijing, 100101, China. tbzhao@ioz.ac.cn.
Ye-Guang ChenGuangzhou National Laboratory, Guangzhou, 510005, China. ygchen@tsinghua.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is one of the most common malignancies with poor prognosis. The use of organoids to simulate gastric cancer has rapidly developed over the past several years. Patient-derived gastric cancer organoids serve as in vitro models that closely mimics donor characteristics, offering new opportunities for both basic and applied research. The "Human Gastric Cancer Organoid" is part of a series of guidelines for human gastric cancer organoids in China, jointly drafted by experts from the Chinese Society for Cell Biology and its branches, and initially released on October 29, 2024. This standard outlines terminology, technical requirements, assessment protocols, and applies to production, evaluation procedures, and quality control for human gastric cancer organoids. The publication of this guideline aims to assist institutions in endorsing, establishing, and applying best practices, advancing the international standardization of human gastric cancer organoids for clinical development and therapeutic application.

Indexed as

DefinitionsGastric cancer organoidsHuman stomachLabelingStandardStorageTechnical requirementsTermsTransportation

Identifiers

PMID39729207
PMCPMC11680512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.